Form 4: Rocket Pharmaceuticals Insider Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
Rocket Pharmaceuticals, Inc. reports that General Counsel Martin Wilson sold shares to cover tax obligations related to vested Restricted Stock Units.
Summary
- Martin Wilson, General Counsel for Rocket Pharmaceuticals, Inc., sold 662 shares of common stock on May 19, 2026.
- The sale was conducted to cover tax withholding obligations arising from the vesting of Restricted Stock Units (RSUs).
- The transaction price was $3.014 per share.
- Following the transaction, Mr. Wilson beneficially owns 677,977 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a routine event for covering tax obligations related to equity compensation and does not indicate a change in the insider's long-term investment thesis.
Negatives
- Insider selling can sometimes be perceived negatively by the market, although this sale was for tax purposes.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Management Comments
- The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, often related to routine events like tax payments upon vesting of equity awards, rather than indicative of a change in the insider's fundamental view of the company's prospects.
Stakeholder Impact
- Shareholders: The sale is a routine event and not expected to have a significant impact on the share price. It confirms the standard practice of covering tax liabilities from equity awards.
- Employees: Highlights the tax implications of RSU vesting for employees who receive similar compensation.
- Management: Demonstrates adherence to SEC disclosure requirements for insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/19/2026 | Transaction Date (Sale of common stock) |
| 05/21/2026 | Date of Signature on Form 4 |
Keywords
Form 4, Insider Transaction, Rocket Pharmaceuticals, RCKT, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.